Heparin-like polysaccharides markedly reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

被引：0
|
作者：
Kakonen, R. S. [1 ]
Kakonen, S. [2 ]
Mohammad, K. S. [3 ]
Rissanen, J. P. [1 ]
Halleen, J. M. [1 ]
Warri, A. [4 ]
Nissinen, L. [4 ]
Pihlavisto, M. [4 ]
Chirgwin, J. M. [3 ]
Salmivirta, M. [5 ]
Marjamaki, A. [4 ]
Guise, T. A. [3 ]
机构：
[1] Pharmatest Serv Ltd, Turku, Finland
[2] Univ Turku, Dept Anat, SF-20500 Turku, Finland
[3] Univ Virginia, Charlottesville, VA 22903 USA
[4] BioTie Therapies Corp, Turku, Finland
[5] Turku Ctr Biotechnol, Turku, Finland
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
T241
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [1] Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis
    Pollari, Sirkku
    Kakonen, Rami
    Mohammad, Khalid S.
    Rissanen, Jukka P.
    Halleen, Jussi
    Warri, Anni
    Nissinen, Liisa
    Pihlavisto, Marjo
    Marjamaki, Anne
    Perala, Merja
    Guise, Theresa
    Kallioniemi, Olli
    Kakonen, Sanna-Maria
    CANCER RESEARCH, 2011, 71
  • [2] Heparin-like Polysaccharides Reduce Osteolytic Bone Destruction and Tumor Growth in a Mouse Model of Breast Cancer Bone Metastasis
    Pollari, Sirkku
    Kakonen, Rami S.
    Mohammad, Khalid S.
    Rissanen, Jukka P.
    Halleen, Jussi M.
    Warri, Anni
    Nissinen, Liisa
    Pihlavisto, Marjo
    Marjamaki, Anne
    Perala, Merja
    Guise, Theresa A.
    Kallioniemi, Olli
    Kakonen, Sanna-Maria
    MOLECULAR CANCER RESEARCH, 2012, 10 (05) : 597 - 604
  • [3] A low-molecular-weight heparin markedly reduced osteolytic bone destruction in a mouse model of breast cancer bone metastases.
    Käkönen, SM
    Mohammad, KS
    Käkönen, RS
    Marjamäki, A
    Wärri, A
    Salmivirta, M
    Guise, TA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S63 - S63
  • [4] OSTEOLYTIC BONE METASTASIS IN BREAST-CANCER
    YONEDA, T
    SASAKI, A
    MUNDY, GR
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 73 - 84
  • [5] Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model
    Iwasaki, T
    Mukai, M
    Tsujimura, T
    Tatsuta, M
    Nakamura, H
    Terada, N
    Akedo, H
    INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (04) : 381 - 387
  • [6] Sagopilone Inhibits Breast Cancer Bone Metastasis and Bone Destruction Due to Simultaneous Inhibition of Both Tumor Growth and Bone Resorption
    Strube, Anne
    Hoffmann, Jens
    Stepina, Elizaveta
    Hauff, Peter
    Klar, Ulrich
    Kaekoenen, Sanna-Maria
    CLINICAL CANCER RESEARCH, 2009, 15 (11) : 3751 - 3759
  • [7] Effects of osteolytic bone metastases on bone mass and bone strength in the mouse: Validation of a pre-clinical model of breast cancer metastasis to bone.
    Allen, MJ
    Arrington, SA
    Margulies, BS
    Schoonmaker, JE
    Mann, KA
    Damron, TA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S124 - S124
  • [8] Immunization With RANKL Inhibits Osteolytic Bone Metastasis in Breast Cancer
    Kim, Bora
    Cho, Yong Jin
    Park, Mineon
    Lim, Wonbong
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (01) : 1 - 12
  • [9] Mitophagy deficiency promotes osteolytic bone metastasis in breast cancer
    Deng, Rong
    Zhang, Hai-Liang
    Cai, Rui-Zhao
    Tang, Jun
    Zhu, Xiao-Feng
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Templated Three-Dimensional Engineered Bone Matrix as a Model for Breast Cancer Osteolytic Bone Metastasis Process
    Sun, Manman
    Huang, Ke
    Luo, Xueshi
    Li, Hong
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 8391 - 8403
12345